Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ORMP Stock Alerts $2.46 +0.16 (+6.96%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Oramed Pharmaceuticals Stock Price Performance5 Day Performance+4.68%1 Month Performance-15.75%3 Month Performance+6.03%6 Month Performance+32.97%Year-To-Date Performance+6.49%1 Year Performance+8.37% Receive ORMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad DTIMy top 100 stocks…We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well.Get some cool freebies right here. ORMP Stock Chart for Sunday, April, 28, 2024 ORMP Chart by TradingView Oramed Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$2.30$2.46+6.96%$2.48$2.3184,471 shs$99.68 million04/25/2024$2.37$2.30-2.95%$2.37$2.20107,258 shs$93.20 million04/24/2024$2.35$2.37+0.85%$2.39$2.3140,834 shs$96.03 million04/23/2024$2.33$2.35+0.86%$2.43$2.3431,031 shs$95.22 million04/22/2024$2.27$2.33+2.64%$2.39$2.2559,020 shs$94.41 million04/19/2024$2.20$2.27+3.18%$2.30$2.18113,647 shs$91.98 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$2.33$2.20-5.58%$2.37$2.14240,759 shs$89.14 million04/17/2024$2.40$2.33-2.92%$2.41$2.27149,862 shs$94.41 million04/16/2024$2.42$2.40-0.83%$2.45$2.33116,858 shs$97.25 million04/15/2024$2.52$2.42-3.97%$2.57$2.40152,599 shs$98.06 million04/12/2024$2.58$2.52-2.33%$2.64$2.5072,512 shs$102.11 million04/11/2024$2.66$2.58-3.01%$2.69$2.57108,919 shs$104.54 million04/10/2024$2.69$2.66-1.12%$2.73$2.6463,588 shs$107.78 million04/09/2024$2.77$2.69-2.89%$2.81$2.66116,299 shs$109.00 million04/08/2024$2.61$2.77+6.13%$2.80$2.6484,270 shs$112.24 million04/05/2024$2.61$2.61$2.69$2.51171,934 shs$105.76 million04/04/2024$2.75$2.61-5.09%$2.80$2.61177,559 shs$105.76 million04/03/2024$2.80$2.75-1.79%$2.80$2.7297,919 shs$111.43 million04/02/2024$2.83$2.80-1.06%$2.83$2.7381,209 shs$113.46 million04/01/2024$2.92$2.83-3.08%$2.95$2.78112,863 shs$114.67 million03/29/2024$2.92$2.92$3.14$2.78211,195 shs$118.32 million03/28/2024$2.82$2.92+3.55%$3.14$2.79209,506 shs$118.32 million03/27/2024$2.72$2.82+3.68%$2.84$2.66160,213 shs$114.27 million03/26/2024$2.76$2.72-1.45%$2.83$2.6988,737 shs$110.21 million03/25/2024$2.91$2.76-5.15%$2.89$2.71167,534 shs$111.84 million03/22/2024$2.80$2.91+3.93%$2.93$2.7868,844 shs$117.91 million03/21/2024$2.96$2.80-5.41%$3.03$2.79141,277 shs$113.45 million03/20/2024$2.83$2.96+4.59%$2.99$2.82136,261 shs$119.94 million03/19/2024$2.81$2.83+0.71%$2.91$2.7880,742 shs$114.67 million03/18/2024$2.92$2.81-3.77%$2.96$2.7992,944 shs$113.86 million03/15/2024$2.68$2.92+8.96%$2.92$2.6979,678 shs$118.32 million03/14/2024$2.77$2.68-3.25%$2.80$2.6597,837 shs$108.59 million03/13/2024$2.86$2.77-3.15%$2.89$2.74124,349 shs$112.24 million03/12/2024$2.94$2.86-2.72%$2.94$2.77169,155 shs$115.89 million03/11/2024$2.98$2.94-1.34%$3.07$2.9199,897 shs$119.13 million03/08/2024$2.86$2.98+4.20%$3.01$2.8696,261 shs$120.21 million03/07/2024$2.87$2.86-0.35%$3.01$2.80148,116 shs$115.37 million03/06/2024$3.26$2.87-11.96%$3.20$2.75490,308 shs$115.78 million03/05/2024$3.25$3.26+0.31%$3.29$3.19109,021 shs$131.51 million03/04/2024$3.42$3.25-4.97%$3.37$3.21125,170 shs$131.11 millionRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide03/01/2024$3.29$3.42+3.95%$3.45$3.29109,061 shs$137.96 million02/29/2024$3.41$3.29-3.52%$3.48$3.21200,189 shs$132.72 million02/28/2024$3.58$3.41-4.75%$3.60$3.37246,782 shs$137.56 million02/27/2024$3.55$3.58+0.85%$3.67$3.50223,589 shs$144.42 million02/26/2024$3.46$3.55+2.60%$3.61$3.45229,958 shs$143.21 million02/23/2024$3.30$3.46+4.85%$3.51$3.28316,263 shs$139.58 million02/22/2024$3.21$3.30+2.80%$3.30$3.13482,400 shs$133.12 million02/21/2024$3.15$3.21+1.90%$3.21$3.03114,169 shs$129.49 million02/20/2024$3.14$3.15+0.32%$3.21$3.08402,319 shs$127.07 million02/19/2024$3.14$3.14$3.15$3.0576,900 shs$126.67 million02/16/2024$3.14$3.14$3.15$3.0576,967 shs$126.67 million02/15/2024$3.13$3.14+0.32%$3.26$3.10430,163 shs$126.67 million02/14/2024$3.03$3.13+3.30%$3.18$3.00113,857 shs$126.26 million02/13/2024$3.17$3.03-4.42%$3.14$2.99209,036 shs$122.23 million02/12/2024$2.85$3.17+11.23%$3.27$3.02328,793 shs$127.88 million02/09/2024$2.69$2.85+5.95%$2.89$2.69104,853 shs$114.97 million02/08/2024$2.84$2.69-5.28%$2.83$2.6894,875 shs$108.52 million02/07/2024$2.83$2.84+0.35%$2.95$2.82127,551 shs$114.56 million02/06/2024$2.62$2.83+8.02%$2.90$2.62172,952 shs$114.16 million02/05/2024$2.75$2.62-4.73%$2.73$2.58141,831 shs$105.69 million02/02/2024$2.83$2.75-2.83%$2.98$2.65140,984 shs$110.93 million02/01/2024$3.00$2.83-5.51%$2.98$2.76222,983 shs$114.16 million01/31/2024$2.98$3.00+0.50%$3.29$2.86563,421 shs$120.82 million01/30/2024$2.58$2.98+15.50%$2.99$2.63553,646 shs$120.21 million01/29/2024$2.32$2.58+11.21%$2.60$2.34255,790 shs$104.08 million Related Companies: IO Biotech Stock Chart Genelux Stock Chart Abeona Therapeutics Stock Chart ProPhase Labs Stock Chart PMV Pharmaceuticals Stock Chart Anixa Biosciences Stock Chart Allakos Stock Chart Vaccitech Stock Chart DiaMedica Therapeutics Stock Chart SELLAS Life Sciences Group Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.